Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3250
+0.1250 (5.68%)
NASDAQ · Last Trade: Sep 22nd, 3:56 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors